Unverified50% confidenceFactExact time
Anti-amyloid monoclonal antibody drugs carry a risk of ARIA, with approximately 12%–35% of patients experiencing ARIA of varying severity.
1
Sources
50%
Confidence
Long-term
Relevance
8/30/2026
First Seen
Sources
Related Entities
Related Claims
Cite This Claim
Stable URI
https://kongchang.com/claim/823842API
curl https://kongchang.com/api/v1/knowledge/claims/823842MCP
get_claim(id=823842)